Adverse outcome pathway approach for in silico assessment of drug-induced cardiotoxicity caused by hERG inhibition.
Adverse outcome pathway approach for in silico assessment of drug-induced cardiotoxicity caused by hERG inhibition.
Use code EQ20 to get 20% OFF on your first order!
